@article{7f86ae08aa8f4edc87f81987127f6093,
title = "Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)",
abstract = "We performed a dose-escalation trial to determine the maximum tolerated dose (MTD) of intensity-modulated radiotherapy (IMRT) with standard concurrent and sequential-dose temozolomide (TMZ) in patients with glioblastoma multiforme.",
keywords = "radiotherapy, radiotherapy",
author = "Mario Balducci and Francesco Deodato and Vincenzo Valentini and Mariangela Massaccesi and Milena Ferro and Savino Cilla and Gabriella Macchia and Morganti, {Alessio Giuseppe}",
year = "2013",
doi = "10.1007/s10147-012-0462-0",
language = "English",
volume = "18",
pages = "784--791",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Churchill Livingstone:1-3 Baxter's Place, Leith Walk, Edinburgh EH1 3AF United Kingdom:011 44 207 8962117, INTERNET: http://www.churchillmed.com/home.html, Fax: 011 44 207 8962145",
}